Skip to Menu Skip to Search Contact Us Global Websites & Languages Skip to Content
US Flag

You are accessing SGS’s website from the USA.

Visit the US website instead

Stay on the global website and remember my choice

Our white papers and technical bulletins are written by industry experts from many different fields, exploring and commentating on a range of complex subjects.

Cell Substrate Characterisation: Genetic Stability and Identity Testing at SGS (Glasgow) Cell Substrate Characterization: Genetic Stability & Identity Testing at SGS

Learn about genetic stability and identity testing, key requirements for regulatory approval of therapeutic biological products produced using a cell bank system.

Request a Copy

Transmission Electron Microscopy: Applications in Biosafety Testing Transmission Electron Microscopy: Applications in Biosafety Testing

This white paper looks at the role Transmission Electron Microscopy (TEM) plays in biological sciences and in the assessment of biological safety, particularly in virology.

Request a Copy

Nucleic Acid Amplification Techniques Nucleic Acid Amplification Techniques (NAT) to Address Biosafety of Biological Therapies

Over the past 15 years, nucleic acid amplification techniques (NAT), also referred to as polymerase chain reaction (PCR), have played an increasingly important role in the characterization and evaluation of biosafety for human biological therapies.

Request a Copy

Right to know Act White paper thumbnail California Cleaning Products: Right to Know Act

The California Cleaning Product Right to Know Act of 2017 is the first legislation in the United States requiring cleaning products to publicly disclose a defined and regulated list of ingredients. This white paper provides an introduction to the Act and details the products covered and the requirements for disclosure.

Request a Copy

Mycoplasma Detection of Mycoplasma in Biopharmaceuticals, Vaccines, and Gene Cell Therapies

The detection of mycoplasma contamination is of utmost concern in bio-therapeutic and vaccine manufacturing. Now that streamlined assay validation procedures and GMP validated NAT tests are readily available, these methods can provide manufacturers with confidence in results required in production and batch release of products.

Request a Copy

Understanding California Proposition 65 (Prop 65) Developing Effective Risk Mitigation Practices in Response to California Proposition 65

Businesses operating in California, USA, need to understand Proposition 65 (Prop 65). In this white paper we explain Prop 65 and consider effective risk mitigation practices.

Request a Copy

Identification of Surface Impurities and Particles by Means of Special Analysis Methods Identification of Surface Impurities and Particles by Means of Special Analysis Methods

This paper describes some special analytical techniques, their advantages and disadvantages and their application for particle material identification as well as for surface contamination characterization.

Request a Copy

Determining the Structure of Impurities White Paper Determining the Structure of Impurities

In the pharmaceutical industry, impurities can arise at numerous points in the various processes used. They could occur during research and development, but also during production of the active substances.

Request a Copy

Academic Collaboration with Contract Research Organizations Academic Collaboration with Contract Research Organizations: Reaching Out to the Right Expertise at the Right Time

Drug development is a lengthy and winding road with many obstacles and challenges to be overcome.

Request a Copy

European Union ROHS2 thumbnail European Union ROHS2 - Understanding Requirements and Compliance Strategies

The EU’s RoHS2 Directive restricts the use of certain hazardous substances in electrical and electronic equipment. In this white paper we consider the terms of this regulation and the ways stakeholders can ensure compliance.

Request a Copy